BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

609 related articles for article (PubMed ID: 10800633)

  • 1. Preclinical pharmacology of desloratadine, a selective and nonsedating histamine H1 receptor antagonist. 1st communication: receptor selectivity, antihistaminic activity, and antiallergenic effects.
    Kreutner W; Hey JA; Anthes J; Barnett A; Young S; Tozzi S
    Arzneimittelforschung; 2000 Apr; 50(4):345-52. PubMed ID: 10800633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical pharmacology of desloratadine, a selective and nonsedating histamine H1 receptor antagonist. 2nd communication: lack of central nervous system and cardiovascular effects.
    Kreutner W; Hey JA; Chiu P; Barnett A
    Arzneimittelforschung; 2000 May; 50(5):441-8. PubMed ID: 10858871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-allergic and anti-inflammatory properties of a potent histamine H1 receptor antagonist, desloratadine citrate disodium injection, and its anti-inflammatory mechanism on EA.hy926 endothelial cells.
    Jie Q; Kodithuwakku ND; Yuan X; He G; Chen M; Xu S; Wu Y
    Eur J Pharmacol; 2015 May; 754():1-10. PubMed ID: 25704613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative antiallergic effects of second-generation H1-antihistamines ebastine, cetirizine and loratadine in preclinical models.
    Llupià J; Gras J; Llenas J
    Arzneimittelforschung; 2003; 53(2):93-7. PubMed ID: 12642964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-anaphylactic activity of the novel selective histamine H1 receptor antagonist mizolastine in the rodent.
    Levrier J; Duval D; Prouteau M; Voltz C; Berry CN; Lloyd KG; Scatton B
    Arzneimittelforschung; 1995 May; 45(5):559-68. PubMed ID: 7541995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo and in vitro interaction of the novel selective histamine H1 receptor antagonist mizolastine with H1 receptors in the rodent.
    Benavides J; Schoemaker H; Dana C; Claustre Y; Delahaye M; Prouteau M; Manoury P; Allen J; Scatton B; Langer SZ
    Arzneimittelforschung; 1995 May; 45(5):551-8. PubMed ID: 7612054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of E-4716, a new antihistaminic with antiallergic properties, on chemical mediators induction of immunologic reactions.
    Gutiérrez B; Dordal A; Fort M; Galicia J; Farré AJ
    Methods Find Exp Clin Pharmacol; 1996; 18(6):397-406. PubMed ID: 8892269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the novel antiallergic agent HSR-609: its penetration into the central nervous system in mice and guinea pigs and its selectivity for the histamine H1-receptor.
    Kakiuchi M; Ohashi T; Musoh K; Kawamura K; Morikawa K; Kato H
    Jpn J Pharmacol; 1997 Apr; 73(4):291-8. PubMed ID: 9165365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Desloratadine citrate disodium injection, a potent histamine H(1) receptor antagonist, inhibits chemokine production in ovalbumin-induced allergic rhinitis guinea pig model and histamine-induced human nasal epithelial cells via inhibiting the ERK1/2 and NF-kappa B signal cascades.
    Chen M; Xu S; Zhou P; He G; Jie Q; Wu Y
    Eur J Pharmacol; 2015 Nov; 767():98-107. PubMed ID: 26455479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Desloratadine inhibits constitutive and histamine-stimulated nuclear factor-kappaB activity consistent with inverse agonism at the histamine H1 Receptor.
    Wu RL; Anthes JC; Kreutner W; Harris AG; West RE
    Int Arch Allergy Immunol; 2004 Dec; 135(4):313-8. PubMed ID: 15564772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The in vitro and in vivo ocular pharmacology of olopatadine (AL-4943A), an effective anti-allergic/antihistaminic agent.
    Yanni JM; Stephens DJ; Miller ST; Weimer LK; Graff G; Parnell D; Lang LS; Spellman JM; Brady MT; Gamache DA
    J Ocul Pharmacol Ther; 1996; 12(4):389-400. PubMed ID: 8951675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of loratadine on immediate and delayed type hypersensitivity reactions.
    Tasaka K; Kamei C; Akagi M; Mio M; Izushi K; Yoshida T; Nakamura S
    Arzneimittelforschung; 1995 Jul; 45(7):796-804. PubMed ID: 8573225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical pharmacology of bilastine, a new selective histamine H1 receptor antagonist: receptor selectivity and in vitro antihistaminic activity.
    Corcóstegui R; Labeaga L; Innerárity A; Berisa A; Orjales A
    Drugs R D; 2005; 6(6):371-84. PubMed ID: 16274260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticholinergic effects of desloratadine, the major metabolite of loratadine, in rabbit and guinea-pig iris smooth muscle.
    Cardelús I; Antón F; Beleta J; Palacios JM
    Eur J Pharmacol; 1999 Jun; 374(2):249-54. PubMed ID: 10422766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Animal pharmacology of the selective histamine H1-receptor antagonist tazifylline.
    Poizot A; Dumez D; Ferrandon P; Lefournier C; Michel A; Armstrong JM
    Arzneimittelforschung; 1986 Apr; 36(4):695-702. PubMed ID: 2424463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the pharmacology of the novel histamine H3 receptor agonist Sch 50971.
    Hey JA; Aslanian R; Bolser DC; Chapman RW; Egan RW; Rizzo CA; Shih NY; Fernandez X; McLeod RL; West R; Kreutner W
    Arzneimittelforschung; 1998 Sep; 48(9):881-8. PubMed ID: 9793613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical characterization of desloratadine, a potent antagonist of the human histamine H(1) receptor.
    Anthes JC; Gilchrest H; Richard C; Eckel S; Hesk D; West RE; Williams SM; Greenfeder S; Billah M; Kreutner W; Egan RE
    Eur J Pharmacol; 2002 Aug; 449(3):229-37. PubMed ID: 12167464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo pharmacological characterisation of bilastine, a potent and selective histamine H1 receptor antagonist.
    Corcóstegui R; Labeaga L; Innerárity A; Berisa A; Orjales A
    Drugs R D; 2006; 7(4):219-31. PubMed ID: 16784247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and biological activity evaluation of desloratadine analogues as H1 receptor antagonists.
    Lin Y; Wang Y; Sima LF; Wang DH; Cao XH; Chen LG; Chen B
    Bioorg Med Chem; 2013 Jul; 21(14):4178-85. PubMed ID: 23719280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the effects of desloratadine and levocetirizine on histamine-induced wheal, flare and itch in human skin.
    Denham KJ; Boutsiouki P; Clough GF; Church MK
    Inflamm Res; 2003 Oct; 52(10):424-7. PubMed ID: 14520518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.